Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
Advances in Radiation Oncology|March 2, 2026
Comparison of 3 vs 5 Fraction Single Isocenter Radiosurgery for Brain MetastasesLuke A Moradi, Richard A Popple, Roman L Travis, et al.
Theranostics|January 9, 2026
Quantitative dynamic granzyme B PET imaging to characterize novel combination immunotherapy response in preclinical glioblastoma modelsCarlos A Gallegos, Yun Lu, Patrick N Song, et al.
Scientific Reports|September 19, 2018
Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 ExpressionGregory K Friedman, Joshua D Bernstock, Dongquan Chen, et al.
Human Gene Therapy|July 14, 2020
Design and Rationale for First-in-Human Phase 1 Immunovirotherapy Clinical Trial of Oncolytic HSV G207 to Treat Malignant Pediatric Cerebellar Brain TumorsJoshua D Bernstock, Asim K Bag, John Fiveash, et al.
The Journal of Biological Chemistry|May 18, 2006
Surface expression of ASIC2 inhibits the amiloride-sensitive current and migration of glioma cellsWanda H Vila-Carriles, Gergely Gy Kovacs, Biljana Jovov, et al.
The Journal of Biological Chemistry|February 14, 2003
Acid-sensing ion channels in malignant gliomasBakhrom K Berdiev, Jiazeng Xia, Lee Anne McLean, et al.
Cancer Gene Therapy|March 29, 2019
Safety and efficacy of oncolytic HSV-1 G207 inoculated into the cerebellum of miceJoshua D Bernstock, Nunzio Vicario, Rong Li, et al.
Neurosurgical Focus|February 1, 2021
Safety and interim survival data after intracranial administration of M032, a genetically engineered oncolytic HSV-1 expressing IL-12, in pet dogs with sporadic gliomasNidal B Omar, R Timothy Bentley, David K Crossman, et al.
Molecular Therapy Oncolytics|October 6, 2015
Pediatric cancer gone viral. Part II: potential clinical application of oncolytic herpes simplex virus-1 in childrenGregory K Friedman, Elizabeth A Beierle, George Yancey Gillespie, et al.
Scientific Reports|July 29, 2021
Positron emission tomography imaging with <sup>89</sup>Zr-labeled anti-CD8 cys-diabody reveals CD8<sup>+</sup> cell infiltration during oncolytic virus therapy in a glioma murine modelBenjamin B Kasten, Hailey A Houson, Jennifer M Coleman, et al.
Pageof 14